422 related articles for article (PubMed ID: 27049564)
21. HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis.
Brum DG; Barreira AA; dos Santos AC; Kaimen-Maciel DR; Matiello M; Costa RM; Deghaide NH; Costa LS; Louzada-Junior P; Diniz PR; Comini-Frota ER; Mendes-Junior CT; Donadi EA
Mult Scler; 2010 Jan; 16(1):21-9. PubMed ID: 19995845
[TBL] [Abstract][Full Text] [Related]
22. Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder.
Kang ES; Min JH; Lee KH; Kim BJ
Ann Lab Med; 2012 Sep; 32(5):331-8. PubMed ID: 22950068
[TBL] [Abstract][Full Text] [Related]
23. Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population.
Ogasawara M; Meguro A; Sakai T; Mizuki N; Takahashi T; Fujihara K; Tsuneoka H; Shikishima K
Jpn J Ophthalmol; 2016 May; 60(3):198-205. PubMed ID: 27012886
[TBL] [Abstract][Full Text] [Related]
24. Detection of aquaporin-4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania.
Sakalauskaitė-Juodeikienė E; Armalienė G; Kizlaitienė R; Bagdonaitė L; Giedraitienė N; Mickevičienė D; Rastenytė D; Kaubrys G; Jatužis D
Brain Behav; 2018 Nov; 8(11):e01129. PubMed ID: 30284401
[TBL] [Abstract][Full Text] [Related]
25. A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.
Arellano B; Hussain R; Miller-Little WA; Herndon E; Lambracht-Washington D; Eagar TN; Lewis R; Healey D; Vernino S; Greenberg BM; Stüve O
PLoS One; 2016; 11(4):e0152720. PubMed ID: 27054574
[TBL] [Abstract][Full Text] [Related]
26. Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders.
Matsushita T; Matsuoka T; Isobe N; Kawano Y; Minohara M; Shi N; Nishimura Y; Ochi H; Kira J
Tissue Antigens; 2009 Feb; 73(2):171-6. PubMed ID: 19140826
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
[TBL] [Abstract][Full Text] [Related]
28. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
29. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
[TBL] [Abstract][Full Text] [Related]
30. Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region.
Dale GH; Svendsen KB; Gjelstrup MC; Christensen T; Houen G; Nielsen E; Bek T; Petersen T
Acta Neurol Scand; 2018 Jun; 137(6):582-588. PubMed ID: 29359475
[TBL] [Abstract][Full Text] [Related]
31. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
32. What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients.
Hamid SHM; Whittam D; Mutch K; Linaker S; Solomon T; Das K; Bhojak M; Jacob A
J Neurol; 2017 Oct; 264(10):2088-2094. PubMed ID: 28840314
[TBL] [Abstract][Full Text] [Related]
33. HLA association in MOG-IgG- and AQP4-IgG-related disorders of the CNS in the Dutch population.
Bruijstens AL; Wong YYM; van Pelt DE; van der Linden PJE; Haasnoot GW; Hintzen RQ; Claas FHJ; Neuteboom RF; Wokke BHA
Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32198229
[TBL] [Abstract][Full Text] [Related]
34. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW
J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529
[TBL] [Abstract][Full Text] [Related]
35. Reappraisal of aquaporin-4 astrocytopathy in Asian neuromyelitis optica and multiple sclerosis patients.
Matsuoka T; Suzuki SO; Suenaga T; Iwaki T; Kira J
Brain Pathol; 2011 Sep; 21(5):516-32. PubMed ID: 21241398
[TBL] [Abstract][Full Text] [Related]
36. [Clinical concept, etiology and pathology of neuromyelitis optica].
Kurosawa K; Fujihara K
Nihon Rinsho; 2014 Nov; 72(11):1897-902. PubMed ID: 25518368
[TBL] [Abstract][Full Text] [Related]
37. No association of
Yang TT; He Y; Xiang YJ; Ao DH; Wang YY; Zhang Q; He XJ; Zhong SS; Wu J; Liu GZ
Transl Neurosci; 2016; 7(1):76-83. PubMed ID: 28123825
[TBL] [Abstract][Full Text] [Related]
38. Genetic factors for susceptibility to and manifestations of neuromyelitis optica.
Matsushita T; Masaki K; Isobe N; Sato S; Yamamoto K; Nakamura Y; Watanabe M; Suenaga T; Kira JI;
Ann Clin Transl Neurol; 2020 Nov; 7(11):2082-2093. PubMed ID: 32979043
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients.
Kishk NA; Abokrysha NT; Rashed L; Ahmed N
J Clin Neurosci; 2015 Apr; 22(4):670-5. PubMed ID: 25677878
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
